Targeting Focal Adhesion Kinase Renders Pancreatic Cancers Responsive to Checkpoint Immunotherapy

Single-agent immunotherapy has achieved limited clinical benefit to date in patients suffering from pancreatic ductal adenocarcinoma (PDAC). This may be due to the presence of a uniquely immunosuppressive tumor microenvironment (TME). Critical obstacles to immunotherapy in PDAC tumors include a high...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hong, Hegde, Samarth, Knolhoff, Brett L., Zhu, Yu, Herndon, John M., Meyer, Melissa A., Nywening, Timothy M., Hawkins, William G., Shapiro, Irina M., Weaver, David T., Pachter, Jonathan A., Wang-Gillam, Andrea, DeNardo, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935930/
https://www.ncbi.nlm.nih.gov/pubmed/27376576
http://dx.doi.org/10.1038/nm.4123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935930/
https://www.ncbi.nlm.nih.gov/pubmed/27376576
http://dx.doi.org/10.1038/nm.4123

Ejemplares similares